Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive Factors for Recovery in ISSNHL
NCT05112354Phase 2Completed
- Sponsor
- Assiut University
- Start
- Dec 2019
- Primary completion
- Jun 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of prednisolone, Alkindi Sprinkle in idiopathic sudden sensorineural hearing loss (ISSNHL), sponsored by Assiut University. Started Dec 2019; status: completed.
02
Drugs
prednisoloneAlkindi Sprinkle
03
Conditions
idiopathic sudden sensorineural hearing loss (ISSNHL)
Beyond the preview
Go deeper on NCT05112354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05112354.